James Morphy, a partner at Sullivan & Cromwell LLP, has written a fairly thorough report of the 2012 proxy season, available as a pdf. I mention it here primarily to bookmark it. (more…)
Tag Archives | Sullivan & Cromwell
2012 Proxy Access Efforts
James McRitchie, 07/10/2012 ,
As Glyn Holton reported last week, the SEC denied no-action requests from Forest Labs ($FRX) and Medtronic ($MDT). (SEC Delivers For Shareowners On Proxy Access, 6/29/2012) Therefore, shareowners will get an opportunity to vote in favor of proxy access at upcoming shareowner meetings. (more…)